Controlling Hyperactive Immunity With Long-lived Lymphocytes

Clinical trial NCT07473154 · RECRUITING

Trial details

NCT number: NCT07473154
Sponsor: Quell Therapeutics Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Cutaneous Systemic Sclerosis Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)Autoimmune Rheumatologic Disease

Start date: 2026-04-10
Primary completion: 2028-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.